Amyloid beta protein and Alzheimer disease

Square, David
April 1997
CMAJ: Canadian Medical Association Journal;04/01/97, Vol. 156 Issue 7, p1040
Academic Journal
Describes the role of amyloid beta proteins in hydrolytic enzyme stimulation that breaks down the phospholipid building blocks of the brain cell wall in patients with Alzheimer disease. Treatment with nonsteroidal, anti-inflammatory drug-related compound effective against the disease; Effect of the abnormal destruction of phospholipids on energy resources that neurons uses to rebuild its membrane.


Related Articles

  • Amyloid ox-tox transducers. Mattson, Mark P.; Rydel, Russell E. // Nature;8/22/1996, Vol. 382 Issue 6593, p674 

    Reports on two studies which seek to demonstrate how amyloid-beta peptide (a-beta), the factor which initiates and promotes Alzheimer's Disease (AD), interacts with the cell surface to induce activation of microglia. Also how A-beta damages neurons and vascular endothelial cells; The role of...

  • The ins and outs of amyloid-Beta. Beyreuther, Konrad; Masters, Colin L. // Nature;10/16/1997, Vol. 389 Issue 6652, p677 

    Presents research which investigated the possible mechanism to explain how the amyloid-Beta peptide (A-Beta) could damage neurons and lead to Alzheimer's disease. Research by Yan et al in October 16, 1997 edition of `Nature'; Interaction of A-Beta with endoplasmic-reticulum-associated binding...

  • Amyloid has new role in Alzheimer's disease. Boulton, Alison // BMJ: British Medical Journal (International Edition);3/23/96, Vol. 312 Issue 7033, p728 

    Reports that British researchers investigating the protein beta amyloid which is deposited in the brain in Alzheimer's disease have shown its role in vascular damages. Damage of amyloid beta-proteins in the endothelial cells that line the blood vessels; Prevention by superoxide dismutase;...

  • Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor... Games, Dora; Adams, David // Nature;2/9/1995, Vol. 373 Issue 6514, p523 

    Examines an Alzheimer-like neuropathology in transgenic mice overexpressing beta-amyloid precursor protein (APP). Primary pathogenic role for APP; Link between missense mutations in APP and the autosomal dominant forms of Alzheimer disease.

  • Mice found not to have Alzheimer's disease. Cherfas, Jeremy // BMJ: British Medical Journal (International Edition);3/21/92, Vol. 304 Issue 6829, p734 

    Reports the absence of Alzheimer's disease among mice. Effect of beta amyloid protein in the brain structure; Physiological effect of the model developed by Shigeki Kawabata; Implications of the histological finding to the characteristics similar in Alzheimer's disease.

  • An intracellular protein that binds amyloid-Beta peptide and mediates neurotoxicity in Alzheimer's d Shi Du Yan; Fu, Jin // Nature;10/16/1997, Vol. 389 Issue 6652, p689 

    Presents research which concluded that intracellular peptide ERAB may contribute to the neuronal dysfunction associated with Alzheimer's disease. Amyloid-Beta in pathogenesis of Alzheimer's disease; Amyloid-Beta and ERAB; Reaction of ERAB when cell culture is exposed to amyloid-Beta;...

  • Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Duff, Karen; Eckman, Chris // Nature;10/24/1996, Vol. 383 Issue 6602, p710 

    Presents a study of mice constructed expressing wild-type and mutant presenilin genes to establish that the presenilin mutations increase the amount of amyloid-beta42(43) in the brain. The testing of whether presenilin mutations act as true dominants; The indications that the presenilin...

  • Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus. Oikawa, Naoto; Matsubara, Teruhiko; Fukuda, Ryoto; Yasumori, Hanaki; Hatsuta, Hiroyuki; Murayama, Shigeo; Sato, Toshinori; Suzuki, Akemi; Yanagisawa, Katsuhiko // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Amyloid deposition, a crucial event of Alzheimer’s disease (AD), emerges in distinct brain regions. A key question is what triggers the assembly of the monomeric amyloid ß-protein (Aß) into fibrils in the regions. On the basis of our previous findings that gangliosides facilitate...

  • Autosomal dominant Alzheimer disease: a unique resource to study CSF biomarker changes in preclinical AD. Schindler, Suzanne Elizabeth; Fagan, Anne M. // Frontiers in Neurology;Jun2015, Vol. 6, p1 

    Our understanding of the pathogenesis of Alzheimer disease (AD) has been greatly influenced by investigation of rare families with autosomal dominant mutations that cause early onset AD. Mutations in the genes coding for amyloid precursor protein (APP), presenilin 1 (PSEN-1), and presenilin 2...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics